Pathogenic Wnt-beta catenin target genes in macrophages and fibrosis
Pathogenic Wnt-beta catenin target genes in macrophages and fibrosis
批准号:
10651598
负责人:
MONIQUE Evangeline HINCHCLIFF
金额:
$63.41万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-03 至 2024-06-30
关键词:
AccelerationAgeAgingAlveolar MacrophagesAnimal ModelAnimalsAttenuatedBioinformaticsBiologicalBiologyBiopsyBleomycinCell SeparationCellsCessation of lifeCharacteristicsClinicalComplexConnective Tissue DiseasesDataDefectDermalDevelopmentDiseaseEffector CellEnvironmentEsophagusExperimental GeneticsFibrosisFlow CytometryGene ExpressionGene Expression ProfileGene Expression ProfilingGenesGeneticGenetic ModelsGenetic TranscriptionHomeostasisHomologous GeneHumanInjuryIrrigationLinkLongevityLungLung diseasesMacrophageMeasuresMolecularMultiple SclerosisMusNatureOrganOverlapping GenesPathogenicityPathway interactionsPatientsPhenotypePlayPopulationPredispositionProcessPulmonary FibrosisPulmonologyReportingResolutionResourcesRheumatologyRoleSclerodermaSeveritiesSeverity of illnessSignal PathwaySignal TransductionSkinSortingSpeedSystemSystemic SclerodermaTechnical ExpertiseTestingTissue DifferentiationTissuesTransforming Growth Factor betaTransplantationUniversitiesWorkage relatedagedbeta cateninfibrotic lung diseasegain of functionindium-bleomycininjuredloss of functionloss of function mutationlung developmentmonocytemouse modelmultidisciplinarynext generation sequencingnovel therapeuticspreventprogramsprototyperecruitskin disorderskin fibrosissubcutaneoustherapeutic targettranscriptometranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Systemic sclerosis (SSc)/scleroderma, is the prototypic fibrotic disease causing skin and internal organ
fibrosis. Lung fibrosis progression as a patient ages is the leading cause of SSc-related deaths. It is likely that
a common effector cell drives fibrosis in multiple organs in SSc, and our preliminary data demonstrate that
circulating monocytes are recruited to injured tissues where they differentiate into “monocyte-derived”
macrophages. Using a murine model of lung fibrosis, we performed causal genetic experiments and showed
that these monocyte-derived tissue macrophages are critical for the fibrosis development. Unbiased
transcriptional profiling of flow-sorted monocyte-derived alveolar macrophages in mice during lung fibrosis, and
in human alveolar macrophages from lung explants from patients with SSc undergoing transplantation, showed
altered signaling through the Wnt/β-catenin pathway. We found that genetic loss-of- function in Wnt/β-catenin
signaling in murine lung macrophages did not affect fibrosis severity, but sped the resolution of fibrosis. These
findings are reminiscent of those in aged animals in which fibrosis persists much longer after bleomycin
administration compared with young mice. Indeed, the persistence of fibrosis after injury is a characteristic
feature of human fibrosis in multiple organs. Furthermore, we found age-related changes in Wnt/β-catenin
pathway components in transcriptomes generated from flow sorted alveolar macrophages collected over the
lifespan of mice (4-24 months). These findings support our hypothesis that a gain of function in Wnt/β-catenin
signaling in monocyte-derived macrophages contributes to the age-related susceptibility to persistent fibrosis in
multiple organs. We propose to test this hypothesis in two interrelated specific aims. In Aim 1, we will
determine whether genetic gain- or loss-of-function of Wnt/β-catenin signaling in monocyte-derived
macrophages cells enhances or prevents the differential susceptibility of aged animals to multiple organ
fibrosis. In Aim 2, we will determine whether a common deregulated Wnt pathway-related gene expression
signature is present in tissue macrophages isolated from the lung and skin of patients with SSc compared to
healthy control subjects. Our previous work using whole skin biopsies from mice and SSc patients,
demonstrated that alterations in the Wnt/β-catenin system are involved with SSc dermal fibrosis. We now
propose to capitalize upon our combined expertise in macrophage biology and Wnt/β-catenin signaling to
determine their contribution to accelerated SSc dermal and lung fibrosis in the aged. Altogether, this proposal
matches a proven investigative team with a compelling hypothesis that stands to transform the way we think
about aging-related fibrosis.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
A review and roadmap of the skin, lung and gut microbiota in systemic sclerosis.
系统性硬化症中皮肤、肺和肠道微生物群的回顾和路线图。
DOI:
10.1093/rheumatology/keab262
发表时间:
2021
期刊:
Rheumatology (Oxford, England)
影响因子:
--
作者:
[Teaw,Shannon, Hinchcliff,Monique, Cheng,Michelle]
通讯作者:
Cheng,Michelle
DOI:
10.1186/s13075-023-03090-y
发表时间:
2023-07-08
期刊:
Arthritis research & therapy
影响因子:
4.9
作者:
[]
通讯作者:
DOI:
10.1186/s13075-023-02990-3
发表时间:
2023-01-20
期刊:
Arthritis research & therapy
影响因子:
4.9
作者:
[]
通讯作者:
Pathogenic Wnt-beta catenin target genes in macrophages and fibrosis
-
批准号:9500544
-
项目类别:
-
资助金额:$70.3万
-
财政年份:2019
-
负责人:MONIQUE Evangeline HINCHCLIFF
-
依托单位:
Predictive Ability of Gene Expression Signatures In Skin as SSc Biomarkers
-
批准号:8886940
-
项目类别:
-
资助金额:$13.0万
-
财政年份:2013
-
负责人:MONIQUE Evangeline HINCHCLIFF
-
依托单位:
Predictive Ability of Gene Expression Signatures In Skin as SSc Biomarkers
-
批准号:8702083
-
项目类别:
-
资助金额:$13.0万
-
财政年份:2013
-
负责人:MONIQUE Evangeline HINCHCLIFF
-
依托单位:
Predictive Ability of Gene Expression Signatures In Skin as SSc Biomarkers
-
批准号:8580663
-
项目类别:
-
资助金额:$13.0万
-
财政年份:2013
-
负责人:MONIQUE Evangeline HINCHCLIFF
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: